Quality Assurance for Cerebrospinal Fluid Protein Analysis: International Consensus by an Internet-Based Group Discussion

Abstract

A group of neurologists and clinical neurochemists representing twelve countries worked towards a consensus on laboratory techniques to improve the quality of analysis and interpretation of cerebrospinal fluid (CSF) proteins. Consensus was approached via a virtual Lotus Notes-based TeamRoom. This new approach respecting multicultural differences, common views, and minority opinions, is available in http://www.teamspace.net/ CSF, presenting the implicit, complementary version of this explicit, printed consensus. Three key recommendations were made: CSF and (appropriately diluted) serum samples should be analyzed together in one analytical run, i.e., with reference to the same calibration curve. Results are evaluated as CSF/serum quotients, taking into account the non-linear, hyperbolic relation between immunoglobulin (Ig)- and albumin-quotients rather than using the linear IgG index or IgG synthesis rate. Controls should include materials with values within the reference ranges (IgM: 0.5-1.5 mg/l; IgA: 1-3 mg/l; IgG: 10-30 mg/l and albumin: 100-300 mg/l). The physiological, methodological and clinical significance of CSF/serum quotients is reviewed. We confirmed the previous consensus on oligoclonal IgG, in particular the usefulness of the five typical interpretation patterns. The group compared current external and internal quality assurance schemes and encouraged all members to maintain national or local traditions. Values for acceptable imprecision in the CSF quality assurance are proposed.

Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF

“…The CSF/serum ratio of 21 : 1 was comparable to the ratio reported for healthy individuals (18 : 1-20 : 1) with intact BBB. 10 The serum findings reproduce the results of earlier studies. In an acute stage of disease, serum S100B was shown to be elevated in unmedicated as well as medicated schizophrenic patients and S100B concentrations in serum were positively correlated with a more severe psychopathology.…”

CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients

“…Paired serum samples were also collected and stored at -80°C. For determination of blood-brain barrier disruption, the ratio of albumin in CSF and serum (Q alb ) was calculated (15). The extent of blood-brain barrier disruption was graded according to the Q alb value as none (≤7.4 × 10 -3 ), slight (>7.4 and ≤10 × 10 -3 ), moderate (>10 and ≤20 × 10 -3 ), and severe (>20 × 10 -3 ).…”

Early Differential Diagnosis of Multiple Sclerosis Using a New Oligoclonal Band Test

“…5,12 However, the methods widely used for OCGB detection require expert laboratories for the correct interpretation of a variety of cases, causing variability of results among different laboratories. 4,6 We recently developed a new method for OCGB detection that shows high sensitivity and definition and that is easier to interpret. 7 Applying this technique, we exclusively found ITGS in MS, CNS infections, and 1 patient with motor neuron disease when 385 neurologic patients were studied.…”